SS-31, also known as Elamipretide, is a synthetic tetrapeptide designed to target mitochondria, protect against oxidative stress, and enhance cellular energy production. It is commonly used in research to study mitochondrial function, cellular bioenergetics, and oxidative damage mitigation.
Price range: $59.00 through $121.00
For laboratory research use only. Not for human or animal use or consumption. Not a drug, food, dietary supplement, or cosmetic. Not approved by the FDA for any medical use.
SS-31 (Elamipretide) is a synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) engineered to selectively target the inner mitochondrial membrane. It binds to cardiolipin, a unique phospholipid crucial for mitochondrial structure and function, stabilizing cristae architecture and enhancing electron transport chain efficiency.
Cardiolipin Stabilization: Preserves mitochondrial membrane structure and cristae organization
Antioxidant Effects: Reduces reactive oxygen species (ROS) and prevents cytochrome c release
Enhanced Bioenergetics: Improves ATP production and mitochondrial efficiency
Cellular Protection: Reduces apoptosis and enhances resilience against oxidative stress
Subcutaneous (SC) Injection: 2–10 mg per dose, 3 times weekly or daily, depending on protocol
Intravenous (IV) Infusion: 0.01–0.25 mg/kg/h over a 4-hour period
Cycle Length: Variable; research suggests careful monitoring for use beyond 4 weeks due to limited human studies
Designed for research purposes only; not intended for human consumption
Dosage and frequency may be adjusted based on experimental objectives and mitochondrial health outcomes
Often studied in models of cardiovascular disease, neurodegeneration, and metabolic dysfunction
Class: Mitochondria-targeted tetrapeptide antioxidant
Primary Research Focus: Mitochondrial protection, oxidative stress mitigation, energy metabolism enhancement
| Strength | 10mg, 25mg |
|---|
Reviews
There are no reviews yet.